Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For th...
PLYMOUTH MEETING, PA., Mar. 5, 2019 /PRNewswire-AsiaNet/-- -- The second Phase 3 study initiation announcement made during the International HPV Awareness DayInovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the initiation and opening of sites to enroll the second portion of the company's Pha...
Authors: LATEST ASIANET NEWS RELEASES